Big demand for Aspen loan hints at deal drought ahead
South Africa’s Aspen Pharmacare has signed syndicated loans totalling around €3.4bn-equivalent, in a deal that saw the sort of chunky oversubscription that lenders say will be commonplace throughout the year, because of lack of supply.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts